194 related articles for article (PubMed ID: 18763162)
1. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
Alsarra IA; Hamed AY; Alanazi FK
Drug Deliv; 2008 Jun; 15(5):313-21. PubMed ID: 18763162
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
Jain SK; Gupta Y; Jain A; Rai K
Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
Liu H; Pan W; Ke P; Dong Y; Ji L
Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive polymeric hydrogels for nasal delivery of acyclovir.
Alsarra IA; Hamed AY; Mahrous GM; El Maghraby GM; Al-Robayan AA; Alanazi FK
Drug Dev Ind Pharm; 2009 Mar; 35(3):352-62. PubMed ID: 18770068
[TBL] [Abstract][Full Text] [Related]
6. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
7. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
Paul S; Kumar A; Yedurkar P; Sawant K
Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of acyclovir in the cat.
Owens JG; Nasisse MP; Tadepalli SM; Dorman DC
J Vet Pharmacol Ther; 1996 Dec; 19(6):488-90. PubMed ID: 8971679
[No Abstract] [Full Text] [Related]
9. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
Law SL; Huang KJ; Chiang CH
J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
[TBL] [Abstract][Full Text] [Related]
11. Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.
Naderkhani E; Erber A; Škalko-Basnet N; Flaten GE
J Pharm Sci; 2014 Feb; 103(2):661-8. PubMed ID: 24395733
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
Dhaliwal S; Jain S; Singh HP; Tiwary AK
AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
[TBL] [Abstract][Full Text] [Related]
13. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses.
Bentz BG; Maxwell LK; Erkert RS; Royer CM; Davis MS; MacAllister CG; Clarke CR
J Vet Intern Med; 2006; 20(3):589-94. PubMed ID: 16734094
[TBL] [Abstract][Full Text] [Related]
15. Multiple oral dosing of valacyclovir in horses and ponies.
Garré B; Baert K; Nauwynck H; Deprez P; De Backer P; Croubels S
J Vet Pharmacol Ther; 2009 Jun; 32(3):207-12. PubMed ID: 19646083
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route.
Ding WX; Qi XR; Fu Q; Piao HS
Drug Deliv; 2007 Feb; 14(2):101-4. PubMed ID: 17364874
[TBL] [Abstract][Full Text] [Related]
17. Development and optimisation of mucoadhesive nanoparticles of acyclovir using design of experiments approach.
Kharia AA; Singhai AK
J Microencapsul; 2015; 32(6):521-32. PubMed ID: 26333938
[TBL] [Abstract][Full Text] [Related]
18. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs.
Yang Q; Hu Q
Eur J Drug Metab Pharmacokinet; 2006; 31(1):17-20. PubMed ID: 16715778
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir.
Al-Dhubiab BE; Nair AB; Kumria R; Attimarad M; Harsha S
Colloids Surf B Biointerfaces; 2015 Dec; 136():878-84. PubMed ID: 26547315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
